D
David W. Johnson
Researcher at University of Queensland
Publications - 2880
Citations - 157072
David W. Johnson is an academic researcher from University of Queensland. The author has contributed to research in topics: Peritoneal dialysis & Kidney disease. The author has an hindex of 160, co-authored 2714 publications receiving 140778 citations. Previous affiliations of David W. Johnson include Minnesota Department of Transportation & Open University.
Papers
More filters
Journal ArticleDOI
Detection of a homologous series of C26-C38 polyenoic fatty acids in the brain of patients without peroxisomes (Zellweger's syndrome).
TL;DR: The brains of patients with inherited abnormalities in peroxisomal structure and function contain greatly increased proportions of a homologous series of unique polyenoic fatty acids with carbon chain lengths ranging from 26 to 38 according to evidence by chemical ionization and electron impact mass spectrometry.
Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload
TL;DR: Icodextrin is a high molecular weight, starch-derived glucose polymer, which is capable of inducing sustained ultrafiltration over prolonged (12-16 hour) peritoneal dialysis dwells as discussed by the authors.
Journal ArticleDOI
Mainstreaming Marine Biodiversity into the SDGs: The Role of Other Effective Area-Based Conservation Measures (SDG 14.5)
Daniela Diz,David W. Johnson,Michael Riddell,Sian Rees,Jessica Battle,Kristina M. Gjerde,Sebastian Hennige,J. Murray Roberts +7 more
TL;DR: In this article, the concept of effective area-based conservation measures (OECMs) is explored in the context of the UN Convention on Biological Diversity (CBD) Aichi Biodiversity Target 11 on marine protected areas and OECMs and its linkages to the Sustainable Development Goals (SDGs).
Journal ArticleDOI
Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload
TL;DR: Icodextrin significantly improved peritoneal ultrafiltration and extended technique survival in PD patients with symptomatic fluid overload, especially those who had substantially impaired peritoneAL ultraf infiltration.
Journal ArticleDOI
Should an oral glucose tolerance test be performed routinely in all renal transplant recipients
K. Armstrong,Johannes B. Prins,Elaine Beller,Scott B. Campbell,Carmel M. Hawley,David W. Johnson,Nicole M. Isbel +6 more
TL;DR: FBG may not be the optimal screening or diagnostic tool for PTD or IGT in RTR and consideration should be given to introducing the OGTT as a routine posttransplantation investigation, although the implications of a pathologic OGTT are still to be determined.